Determining the utility of OPM-MEG in a clinical context
UK only
Project Aim: This project aims to fast-track regulatory approval of a new OPM-MEG system, making it the first, and only OPM-MEG system in the world to be approved for human use!
To take part in this study, contact Christine Embury or Zelekha Seedat.
Magnetoencephalography (MEG) measures the magnetic field of the brain and is a useful clinical tool. Despite this, conventional MEG has not been widely taken up as it is expensive and of limited use. In particular, conventional MEG is inadequate for children and infants as helmets are sized for the average adult; reducing the signal captured, and movement relative to the sensors causes dramatic reductions in data quality (even 5mm movements render data unusable). Whilst the newly designed OPM-MEG system overcomes these issues, critically, the system needs regulatory approval for human use.
This project will fast-track this process by amassing the required information. Specifically, the project will:
Demonstrate the safety of the system and complete all documentation to ensure compliance for human use;
Build devices to ensure system accuracy enabling system validation prior to use;
Test the system in humans to prove benefits over existing scanners;
Demonstrate clinical utility in epilepsy by showing that we can accurately map aberrant brain tissue
This study is for children and people up to the age of 25-years.
To learn more about the study, check out the interviews with lead researchers Christine Embury and Zelekha Seedat: